Quarterly report pursuant to Section 13 or 15(d)

Schedule of net loss per common share (Details)

v3.22.2.2
Schedule of net loss per common share (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Net loss $ (1,225,560) $ (2,921,341) $ (2,537,514) $ (1,093,778) $ (1,124,549) $ (1,276,138) $ (6,684,415) $ (3,494,465)
Weighted Average Outstanding Shares:                
Outstanding shares 45,038,181     44,322,335     44,877,366 44,510,021
Option shares includable [1] 0     0     0 0
 Total 45,038,181     44,322,335     44,877,366 44,510,021
Net loss per share                
Basic $ (0.03)     $ (0.02)     $ (0.15) $ (0.08)
Diluted $ (0.03)     $ (0.02)     $ (0.15) $ (0.08)
Restricted Stock [Member]                
Net loss per share                
Antidilutive Securities excluded from computation of earnings per share, amount 950,000     1,000,000     950,000 1,000,000
Employee Stock [Member]                
Net loss per share                
Antidilutive Securities excluded from computation of earnings per share, amount 72,347     296,504     81,723 244,422
Common Stock [Member]                
Net loss    
Weighted Average Outstanding Shares:                
Outstanding shares 45,038,181     44,322,335     44,877,366 44,510,021
[1] For the three months ended September 30, 2022, and 2021, option shares of 72,347 and 296,504 respectively, were not included as the impact is anti-dilutive.  For the nine months ended September 30, 2022, and 2021, option shares of 81,723 and 244,422 respectively, were not included as the impact is anti-dilutive.